Expanded Portfolio for Biomolecules Purification Announced

Chromatography

Expanded Portfolio for Biomolecules Purification Announced

12 Oct, 2017

Published over 8 years ago. See the latest and most current information on Chromatography.

With the increased interest in the purification of a wider variety of biomolecules, the portfolio of Kromasil 300 Å has been expanded to support these applications.

The Kromasil 300 Å line of HPLC products is now shipping with C18, C8, C4 and diC4 derivatisations for scientists and engineers exploiting selectivity and loadability for purification of API and impurity isolation. In particular, the new Kromasil 300 Å diC4 has different characteristic than a classic C4, enabling new opportunities to remove impurities from peptide and protein crudes.

For more information, visit www.kromasil.com

Latest News

ILM 51.6 Sept 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Connected safety technology company announces CEO appointment and leadership transition
Explore more Arrow
Pollution Solutions Online
Smarter wastewater management helps futureproof distillery operations and protect local watercourses
Explore more Arrow
Petro Online
Improving repeatability in diesel fuel lubricity testing
Explore more Arrow
Chromatography Today
Dr. Anupam Giri joins Chromatography Today as consultant editor to strengthen its technical expertise
Explore more Arrow